Traws Pharma, Inc.TRAWNASDAQ
Loading
Price to Sales HistoryFair Value
Percentile Rank62
3Y CAGR-31.5%
5Y CAGR+89.4%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-31.5%/yr
vs +82.4%/yr prior
5Y CAGR
+89.4%/yr
Recent deceleration
Acceleration
-113.9pp
Decelerating
Percentile
P62
Within normal range
vs 5Y Ago
24.4x
Strong expansion
Streak
1 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 61.01 | -12.4% |
| 2023 | 69.65 | +15.8% |
| 2022 | 60.13 | -68.3% |
| 2021 | 189.92 | -46.4% |
| 2020 | 354.10 | +14041.9% |
| 2019 | 2.50 | -64.7% |
| 2018 | 7.09 | -58.7% |
| 2017 | 17.15 | +846.8% |
| 2016 | 1.81 | -4.9% |
| 2015 | 1.91 | - |